SkyCell

PharmaLifeScience News

...

Pharma Industry Awards Ireland 2025 set to showcase sector innovation

The awards will honour the projects, teams and partnerships transforming the pharmaceutical sector in Ireland.

READ MORE
...

Bain leads $300M investment in startup built on Bristol Myers immune drugs
Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives and advance five drugs that no longer fit its plans.
READ MORE
...

GSK’s speciality medicines soar while generals drop, Q2 results reveal
GSK's Q2 results show that sales of its specialist oncology assets have risen by 42%, while general drug sales were down 6%.
READ MORE

Novartis and Matchpoint enter inflammatory disease partnership worth $1bn

Clinisys acquires Orchard Software to expand laboratory informatics leadership

NICE CEO to step down by year-end

The new European Life Science Strategy has been launched

Ireland 'in the dark' over fate of pharma in Trump tariff deal

Novo Nordisk shares plummet as 2025 guidance is cut, overshadowing new CEO

Medical misinformation and sensationalism in the age of social media

Sovereign AI as the backbone of LSHC GCC innovation: Prioritising data privacy in a digital age

Tidmarsh to stand in for Prasad's role at CBER

Extension trial demonstrates long-term benefit for Lilly Alzheimer’s drug

How a Graduate Student Delivered a Real-Time Soil Moisture Map

Novo cuts guidance, names new CEO as obesity drug challenges mount

Immunocompromised people are susceptible to skin cancer caused directly by beta-HPV

Promega Plasmid Collection, available through Addgene, equips industry and academic researchers with powerful bioluminescent assays that provide deeper insights into endogenous cellular biology

Farxiga and Jardiance pose affordability issues, says Maryland drug board

Prasad’s FDA exit may accelerate cell and gene therapy approvals

Gene-Edited Mosquitoes Block Malaria Transmission
Ellab